Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03786282

Ligand	Ligand name	Chain	PDB	Tanimoto
RUT	RUTIN	A,B	1RY8	0.71
VXX	VANILLATE	A,B	1WB6	0.72
C39	N-[(2S,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)-5-HYDROXY-7-METHYL-2-(1-METHYLETHYL)-8-OXOOCTYL]-2-(3-METHOXYPROPOXY)BENZAMIDE	C,O	2V12	0.72
SYR	SYRINGATE	A,B	1WB5	0.71
FNG	5-AMINOCARBONYL-3-NITROPHENYL-ALPHA-D-GALACTOPYRANOSE	D,E,F,G,H	1LLR	0.83
TMS	N-PROPYL-4-[(E)-2-(3,4,5-TRIMETHOXY-PHENYL)-VINYL]-BENZAMIDE	A,B	1X6W	0.76
DM1	DAUNOMYCIN	A	152D	0.71
DM1	DAUNOMYCIN	A,B,C,D	1O0K	0.71
DM1	DAUNOMYCIN	A	1JO2	0.71
DM1	DAUNOMYCIN	A,B	308D	0.71
DM1	DAUNOMYCIN	A	1D33	0.71
DM1	DAUNOMYCIN	A	110D	0.71
DM1	DAUNOMYCIN	A	1D11	0.71
DM1	DAUNOMYCIN	A	427D	0.71
DM1	DAUNOMYCIN	A	2D34	0.71
DM1	DAUNOMYCIN	A	3F8F	0.71
DM1	DAUNOMYCIN	A	1D10	0.71
DM1	DAUNOMYCIN	A	1DA0	0.71
MUS	4-METHYL-2-OXO-2H-CHROMEN-7-YL 5-(ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO-NON-2-ULOPYRANOSIDONIC ACID	A	1S0J	0.7
1DM	N-(2-MORPHOLIN-4-YL-1-MORPHOLIN-4-YLMETHYL-ETHYL)-3-NITRO-5-(3,4,5-TRIHYDROXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-BENZAMIDE	D,E,F,G,H	1PZI	0.71
A32	(3-NITRO-5-(3-MORPHOLIN-4-YL-PROPYLAMINOCARBONYL)PHENYL)-GALACTOPYRANOSIDE	D,E,F,G,H,L,M,O,P,V,W,X,Y,Z	1JQY	0.74
DM6	4'-EPIDOXORUBICIN	A	1D15	0.71
DM6	4'-EPIDOXORUBICIN	A	1D54	0.71
DM6	4'-EPIDOXORUBICIN	A	1D58	0.71
DM6	4'-EPIDOXORUBICIN	A	1QDA	0.71
DM2	DOXORUBICIN	A	2DR6	0.71
DM2	DOXORUBICIN	A	1P20	0.71
DM2	DOXORUBICIN	A	1I1E	0.71
DM2	DOXORUBICIN	A	151D	0.71
DM2	DOXORUBICIN	A	1D12	0.71
DM2	DOXORUBICIN	A	1DA9	0.71
MUG	4-METHYLUMBELLIFERYL-ALPHA-D-GLUCOSE	A,B,C,D	1CJP	0.72
AI1	N-BENZYL-3-(ALPHA-D-GALACTOS-1-YL)-BENZAMIDE	D,E,F,G,H,L,M,N,O,P	1FD7	0.9
3MB	3-METHOXYBENZAMIDE	A	3PAX	0.8
SHP	(4-HYDROXYMALTOSEPHENYL)GLYCINE	A	1DSR	0.82
A24	(3-NITRO-5-(2-MORPHOLIN-4-YL-ETHYLAMINOCARBONYL)PHENYL)-GALACTOPYRANOSIDE	D,E,F,G,H	1JR0	0.73
C40	N-[(2R,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)-5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL]-2-(3-METHOXYPROPOXY)BENZAMIDE	A	2V13	0.71
GAT	4'-AMINOPHENYL-ALPHA-D-GALACTOPYRANOSIDE	D,E,F,G,H	1EFI	0.75
2TN	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	A	2OTF	0.71
2TN	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	A	2NUV	0.71
2TN	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	A	2OUB	0.71
NBF	[(2-ETHOXY-1-NAPHTHOYL)AMINO]METHYLBORONIC ACID	A	1NY0	0.7
NBF	[(2-ETHOXY-1-NAPHTHOYL)AMINO]METHYLBORONIC ACID	A,B	1YMS	0.7
DH2	(2S,3S)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE	A	1GP5	0.7
DH2	(2S,3S)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE	A	1GP6	0.7
AI7	3-(heptyloxy)benzoic acid	A,B	2O3Z	0.75
15B	N-{3-[4-(3-AMINO-PROPYL)-PIPERAZIN-1-YL]-PROPYL}-3-NITRO-5-(GALACTOPYRANOSYL)-BETA-BENZAMIDE	D,E,F,G,H	1PZJ	0.73
HWG	N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE	A,D	1R20	0.7
7CA	5,7-DIHYDROXY-2-(4-METHOXYPHENYL)-8-(3-METHYLBUTYL)-4-OXO-4H-CHROMEN-3-YL 6-DEOXY-ALPHA-L-MANNOPYRANOSIDE	A	2H44	0.71
CA2	(1S,3R,4R,5S)-1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)CYCLOHEXANECARBOXYLIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	2BT4	0.72
FX3	5-O-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-alpha-L-ribofuranose	A	2VGD	0.72
VNL	4-HYDROXY-3-METHOXYBENZOATE	A,B,C,D	2AHC	0.71
VNL	4-HYDROXY-3-METHOXYBENZOATE	A	1XLR	0.71
DB1	2,3-DIHYDROXYBENZAMIDE	A,B,C	1X71	0.71
DM3	6-DEOXYDAUNOMYCIN	A	1D14	0.72
J15	N-{3-[4-(3-AMINO-PROPYL)-PIPERAZIN-1-YL]-PROPYL}-3-NITRO-5-(GALACTOPYRANOSYL)-ALPHA-BENZAMIDE	D,E,F,G,H	1PZJ	0.73
HBZ	N-{[(4-hydroxyphenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QN7	0.71
NOV	NOVOBIOCIN	A,B	1KIJ	0.73
NOV	NOVOBIOCIN	A,B	1S14	0.73
NOV	NOVOBIOCIN	A	1AJ6	0.73
DZN	DAIDZIN	A,B,C,D,E,F,G,H	2VLE	0.75
2HI	(2S,3R)-2,7-DIHYDROXY-3-(4-HYDROXYPHENYL)-2,3-DIHYDRO-4H-CHROMEN-4-ONE	A	1ZG3	0.72
DQH	(2R,3R)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE	A	1GP5	0.7
DQH	(2R,3R)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE	D,F	2C29	0.7